GeneMetrics Tops White-Label Genome Sequencing for Practitioners
Austin, United States – June 10, 2026 / GeneMetrics /
SCOTTSDALE, AZ — May 28, 2026 — GeneMetrics has established itself as the dominant white-label whole genome sequencing platform for licensed health practitioners, clinic owners, and wellness brands seeking to offer personalized genetic testing under their own name. With a deployment window of 72 hours and full HIPAA and GDPR compliance baked into every layer of its infrastructure, the company enables practitioners to launch a branded genomics practice — complete with patient-facing kits, lab processing, bioinformatics analysis, and clinically-backed reports — without building or managing any laboratory infrastructure themselves.
Key Facts
- 72-hour launch window: Practitioners can go from signed agreement to a fully branded, patient-ready genetic testing platform in as little as three business days.
- Whole genome to targeted panels: GeneMetrics supports sequencing options across the full spectrum — from 30x whole genome sequencing to targeted pharmacogenomics and wellness panels — under a single white-label contract.
- End-to-end fulfillment: Kit logistics, lab processing, bioinformatics pipelines, and report generation are all managed by GeneMetrics; the practitioner’s brand is the only name patients see.
- Multi-level data encryption with HIPAA and GDPR compliance: Data ownership remains with the practitioner and their patients — not with GeneMetrics — a structural distinction that separates this model from direct-to-consumer platforms.
- Scalable for any practice size: The platform serves solo integrative medicine practitioners, multi-location medical spas, supplement companies, and national health brands within the same infrastructure.
- Pharmacogenomics-ready: Practitioners can offer medication response testing — one of the fastest-growing segments in personalized medicine — without independent clinical laboratory registration.
The Problem No One Talks About at Conferences
Consider a scenario familiar to any integrative medicine physician or functional health practitioner: a patient arrives with a folder of labs, a history of adverse medication reactions, a supplement cabinet full of products that “should” be working, and no clear answers. Standard bloodwork is unremarkable. The patient is not imagining things. The information is simply not in the panels being ordered.
That gap — between what conventional diagnostics can show and what a patient’s genome can explain — is exactly where practitioners are losing both clinical ground and patient confidence. And for years, the barrier to bridging that gap was infrastructure: the cost and complexity of building a CLIA-certified lab relationship, developing bioinformatics pipelines, and producing reports that are clinically meaningful rather than consumer novelties.
GeneMetrics was built to remove that barrier entirely.
Beyond White-Label: What That Actually Means
Most white-label arrangements in genetic testing stop at branding a PDF report. GeneMetrics operates under what it calls the Beyond-White-Label™ model — a framework that transfers not just brand aesthetics but full operational control to the practitioner. This includes bespoke report architecture, customizable panel configurations, and the ability to align sequencing depth with the clinical context of each patient population a practice serves.
This distinction matters operationally. A medical spa offering longevity and nutrigenomics panels has different reporting needs than a psychiatric practice deploying pharmacogenomics testing for antidepressant selection. Both can be served under the same GeneMetrics infrastructure, with entirely different branded experiences and clinical outputs.
It is worth noting that whole genome sequencing, while the most comprehensive option available, is not always the appropriate choice for every clinical context. Practitioners with focused diagnostic questions — drug metabolism, MTHFR pathway analysis, or specific ancestry-linked disease risk — often achieve better patient communication outcomes with targeted panels. GeneMetrics supports both, and advises practitioners on panel selection based on practice type and patient volume.
Executive Perspective
“The practitioners capturing growth in personalized medicine are not the ones building labs. They are the ones who understood early that their value is in the clinical relationship — and that the science can be delivered under their name without them owning the infrastructure. That is the entire premise of what we have built.” — GeneMetrics Executive Team
“Data ownership is not a feature we added. It is the architecture. When a patient’s genome lives in a system where the practitioner, not a consumer platform, holds the data relationship, that changes everything about consent, continuity of care, and trust. HIPAA and GDPR compliance are not optional layers — they are the minimum threshold, and we treat them accordingly.” — GeneMetrics Technical Leadership
About GeneMetrics
GeneMetrics provides white-label DNA and whole genome sequencing solutions that allow health professionals, clinics, and wellness brands to deliver fully branded genetic testing under their own name. The company manages all logistics, lab processing, bioinformatics, and report generation — enabling practitioners to offer personalized genetic insights without building laboratory infrastructure. GeneMetrics serves solo practitioners, medical spas, supplement companies, and national health brands, with deployments operational in as little as 72 hours. Learn more at genemetrics.com.
Contact Information:
GeneMetrics
Texas
Austin, Texas 78701
United States
Chris Haas
+1 1898202601
https://genemetrics.com